Dr. Ziwar F. Karabatak, MD

Dr. Karabatak practices at Kettering Independent Medical Group Inc in Dayton, Ohio.

Dr. Karabatak's NPI, 1831172329, was assigned on November 29, 2005. Dr. Karabatak holds Ohio license 35060846.

Dr. Karabatak's primary practice is Kettering Independent Medical Group Inc, at 1380 E Stroop Rd, Dayton, OH 45429 in Montgomery County. The practice phone is (937) 762-1629.

Dr. Karabatak's primary practice is Kettering Independent Medical Group Inc in Dayton, Ohio. Dr. Karabatak is also affiliated with Kettering Health Dayton. The medical group on file is Kettering Health Medical Group. Dmand AI also links Dr. Karabatak to 4 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karabatak practices, 8 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Karabatak's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Karabatak is licensed in Ohio.

CMS data shows 1,771 Medicare services from Dr. Karabatak across 21 procedure codes in 2024, for 875 Medicare patients. Medicare paid $138,778 for them.

CMS counts 875 Medicare patients who saw Dr. Karabatak in 2024. The largest group is 75 to 84, with 372 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Karabatak's median patient age at 73, with 46% women.

In 2024, Dr. Karabatak wrote 7,936 Medicare Part D claims for 1,037 patients. 88% of them were for generic drugs. CMS names the drug for 7,752 of them, across 48 drugs with 11 or more claims each, at $1,002,878 in total drug cost. In 2023, CMS named 7,324 claims across 46 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Karabatak for performance year 2024, reported through an alternative payment model (APM). Dr. Karabatak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 42 procedures of coronary angioplasty and stenting by Dr. Karabatak, more than 78% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Karabatak in 2025. Dr. Karabatak's most frequent co-authors are Raja A. Nazir, MD, Ajay Reddivari, MD and Damian N. Valencia, MD.

CMS Open Payments shows 221 general payments to Dr. Karabatak from 10 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 78% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $65,028.